# Eastern Bankshares, Inc.: financial statements, quarterly

EBC · Nasdaq · CIK 1810546 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ebc.md) · [Financials](/companies/ebc/financials.md) · [Filings](/companies/ebc/filings.md) · [Insiders](/companies/ebc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ebc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [19.6](/filings/0001628280-24-046338.md) | [19.8 d](/filings/0001628280-26-013126.md) | [20.4](/filings/0001628280-25-023680.md) | [28.9](/filings/0001628280-25-039203.md) | [30.1](/filings/0001628280-25-050194.md) | [33.2 d](/filings/0001628280-26-013126.md) | [31.1](/filings/0001628280-26-032760.md) | [32.5](/filings/0001628280-26-054656.md) | [33.0](/filings/0001628280-25-050194.md) | [37.5 d](/filings/0001628280-26-013126.md) | [37.2](/filings/0001628280-26-032760.md) | [38.7](/filings/0001628280-26-054656.md) |
| Interest expense | $m | [65.0](/filings/0001628280-24-046338.md) | [70.3 d](/filings/0001628280-24-006922.md) | [72.7](/filings/0001628280-24-020157.md) | [78.7](/filings/0001628280-24-035518.md) | [96.2](/filings/0001628280-24-046338.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(16.2)](/filings/0001628280-24-046338.md) | [2.3 d](/filings/0001628280-26-013126.md) | [10.3](/filings/0001628280-25-023680.md) | [11.7](/filings/0001628280-25-039203.md) | [2.8](/filings/0001628280-25-050194.md) | [11.4 d](/filings/0001628280-26-013126.md) | [33.7](/filings/0001628280-26-032760.md) | [0.1](/filings/0001628280-26-054656.md) | [(12.2)](/filings/0001628280-25-050194.md) | [(10.4) d](/filings/0001628280-26-013126.md) | [18.6](/filings/0001628280-26-032760.md) | [29.6](/filings/0001628280-26-054656.md) |
| Net income | $m | [59.1](/filings/0001628280-24-046338.md) | [319 d](/filings/0001628280-26-013126.md) | [38.6](/filings/0001628280-25-023680.md) | [26.3](/filings/0001628280-25-039203.md) | [(6.2)](/filings/0001628280-25-050194.md) | [60.8 d](/filings/0001628280-26-013126.md) | [(218)](/filings/0001628280-26-032760.md) | [100](/filings/0001628280-26-054656.md) | [106](/filings/0001628280-25-050194.md) | [99.5 d](/filings/0001628280-26-013126.md) | [65.3](/filings/0001628280-26-032760.md) | [105](/filings/0001628280-26-054656.md) |
| Diluted EPS | $ per share | [0.36](/filings/0001628280-24-046338.md) | not reported | [0.24](/filings/0001628280-25-023680.md) | [0.16](/filings/0001628280-25-039203.md) | [(0.03)](/filings/0001628280-25-050194.md) | not reported | [(1.08)](/filings/0001628280-26-032760.md) | [0.50](/filings/0001628280-26-054656.md) | [0.53](/filings/0001628280-25-050194.md) | not reported | [0.29](/filings/0001628280-26-032760.md) | [0.48](/filings/0001628280-26-054656.md) |
| Basic EPS | $ per share | [0.36](/filings/0001628280-24-046338.md) | not reported | [0.24](/filings/0001628280-25-023680.md) | [0.16](/filings/0001628280-25-039203.md) | [(0.03)](/filings/0001628280-25-050194.md) | not reported | [(1.09)](/filings/0001628280-26-032760.md) | [0.50](/filings/0001628280-26-054656.md) | [0.53](/filings/0001628280-25-050194.md) | not reported | [0.29](/filings/0001628280-26-032760.md) | [0.48](/filings/0001628280-26-054656.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [21.1](/filings/0001628280-23-036768.md) | [21.1](/filings/0001628280-25-008583.md) | [21.2](/filings/0001628280-24-020157.md) | [21.0](/filings/0001628280-24-035518.md) | [25.5](/filings/0001628280-24-046338.md) | [25.6](/filings/0001628280-26-013126.md) | [25.0](/filings/0001628280-25-023680.md) | [25.5](/filings/0001628280-25-039203.md) | [25.5](/filings/0001628280-25-050194.md) | [30.6](/filings/0001628280-26-054656.md) | [30.6](/filings/0001628280-26-032760.md) | [31.1](/filings/0001628280-26-054656.md) |
| Total liabilities | $bn | [18.7](/filings/0001628280-23-036768.md) | [18.2](/filings/0001628280-25-008583.md) | [18.2](/filings/0001628280-24-020157.md) | [18.1](/filings/0001628280-24-035518.md) | [21.8](/filings/0001628280-24-046338.md) | [21.9](/filings/0001628280-26-013126.md) | [21.4](/filings/0001628280-25-023680.md) | [21.8](/filings/0001628280-25-039203.md) | [21.7](/filings/0001628280-25-050194.md) | [26.2](/filings/0001628280-26-054656.md) | [26.3](/filings/0001628280-26-032760.md) | [26.9](/filings/0001628280-26-054656.md) |
| Shareholders' equity | $bn | [2.4](/filings/0001628280-24-046338.md) | [3.0](/filings/0001628280-26-013126.md) | [3.0](/filings/0001628280-25-039203.md) | [3.0](/filings/0001628280-25-050194.md) | [3.7](/filings/0001628280-25-050194.md) | [3.6](/filings/0001628280-26-054656.md) | [3.6](/filings/0001628280-26-054656.md) | [3.7](/filings/0001628280-26-054656.md) | [3.8](/filings/0001628280-25-050194.md) | [4.3](/filings/0001628280-26-054656.md) | [4.3](/filings/0001628280-26-054656.md) | [4.3](/filings/0001628280-26-054656.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [36.0 d](/filings/0001628280-24-046338.md) | [52.8 d](/filings/0001628280-26-013126.md) | [32.6](/filings/0001628280-25-023680.md) | [54.3 d](/filings/0001628280-25-039203.md) | [108 d](/filings/0001628280-25-050194.md) | [88.7 d](/filings/0001628280-26-013126.md) | [47.3](/filings/0001628280-26-032760.md) | [124 d](/filings/0001628280-26-054656.md) | [157 d](/filings/0001628280-25-050194.md) | [104 d](/filings/0001628280-26-013126.md) | [(9.5)](/filings/0001628280-26-032760.md) | [155 d](/filings/0001628280-26-054656.md) |
| Dividends paid | $m | [16.2](/filings/0001628280-24-006922.md) | [18.0](/filings/0001628280-24-006922.md) | [17.9](/filings/0001628280-25-023680.md) | [18.2 d](/filings/0001628280-25-039203.md) | [22.2 d](/filings/0001628280-25-050194.md) | [24.3 d](/filings/0001628280-26-013126.md) | [24.1](/filings/0001628280-26-032760.md) | [26.3 d](/filings/0001628280-26-054656.md) | [25.9 d](/filings/0001628280-25-050194.md) | [29.5 d](/filings/0001628280-26-013126.md) | [28.8](/filings/0001628280-26-032760.md) | [33.1 d](/filings/0001628280-26-054656.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-046338.md) | [0.0 d](/filings/0001628280-26-013126.md) | [0.0](/filings/0001628280-25-023680.md) | [0.0 d](/filings/0001628280-25-039203.md) | [12.6 d](/filings/0001628280-25-050194.md) | [15.1 d](/filings/0001628280-26-013126.md) | [46.5](/filings/0001628280-26-032760.md) | [5.5 d](/filings/0001628280-26-054656.md) | [0.0 d](/filings/0001628280-25-050194.md) | [54.7 d](/filings/0001628280-26-013126.md) | [73.4](/filings/0001628280-26-032760.md) | [73.7 d](/filings/0001628280-26-054656.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [164](/filings/0001628280-23-036768.md) | [162](/filings/0001628280-24-020157.md) | [162](/filings/0001628280-24-035518.md) | [162](/filings/0001628280-24-046338.md) | [163](/filings/0001628280-25-023680.md) | [163](/filings/0001628280-25-039203.md) | [198](/filings/0001628280-25-050194.md) | [201](/filings/0001628280-26-032760.md) | [199](/filings/0001628280-26-054656.md) | [199](/filings/0001628280-25-050194.md) | [223](/filings/0001628280-26-032760.md) | [219](/filings/0001628280-26-054656.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 228,511,552 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001628280-26-054656.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.